Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 9351-9400 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05222906
Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3
PHASE3
Active, not recruiting
43 participants
Started: Apr 18, 2022 · Completed: Oct 30, 2026
1 condition
1 sponsor
22 locations
NCT05542966
Blender Biomarkers: A BLENDER Sub-study to Evaluate the Effect of Oxygen Dose on Oxidative Stress and Organ Injury
N/A
Active, not recruiting
30 participants
Started: Apr 18, 2022 · Completed: Dec 31, 2023
2 conditions
1 sponsor
1 location
NCT05221229
Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )
N/A
Active, not recruiting
29 participants
Started: Apr 17, 2022 · Completed: Jun 1, 2026
4 conditions
2 sponsors
1 location
NCT05370599
Hypertension in Young Adults Trial
PHASE2
Active, not recruiting
120 participants
Started: Apr 15, 2022 · Completed: May 1, 2027
1 condition
1 sponsor
1 location
NCT05180435
Dietary Approaches for Cardiovascular Health Study
NA
Active, not recruiting
42 participants
Started: Apr 15, 2022 · Completed: May 31, 2025
1 condition
2 sponsors
1 location
NCT05177536
Iberdomide Maintenance Therapy in Patients With Multiple Myeloma
PHASE2
Active, not recruiting
40 participants
Started: Apr 15, 2022 · Completed: Jan 31, 2031
1 condition
1 sponsor
2 locations
NCT05113160
Conversation Group Treatment for Aphasia: Does it Work?
NA
Active, not recruiting
162 participants
Started: Apr 15, 2022 · Completed: Apr 30, 2026
1 condition
3 sponsors
3 locations
NCT05201547
Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line
PHASE3
Active, not recruiting
260 participants
Started: Apr 15, 2022 · Completed: Oct 31, 2029
1 condition
2 sponsors
100 locations
NCT05012124
Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SCOPE
NA
Active, not recruiting
297 participants
Started: Apr 15, 2022 · Completed: Mar 31, 2026
3 conditions
2 sponsors
4 locations
NCT05206513
Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy
PHASE3
Active, not recruiting
86 participants
Started: Apr 15, 2022 · Completed: Jun 30, 2026
2 conditions
1 sponsor
38 locations
NCT05283577
Electroacupuncture for the Management of Symptom Clusters in Cancer Patients and Survivors
NA
Active, not recruiting
70 participants
Started: Apr 15, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05374577
Pulmonary Vascular Dysfunction as a Cause of Persistent Exertional Dyspnea After Coronavirus Disease (COVID-19)
N/A
Active, not recruiting
200 participants
Started: Apr 15, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05151172
EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)
NA
Active, not recruiting
530 participants
Started: Apr 15, 2022 · Completed: Jun 30, 2026
1 condition
2 sponsors
53 locations
NCT05248035
PupillOmetry for Prediction of DelirIUM
N/A
Active, not recruiting
213 participants
Started: Apr 15, 2022 · Completed: Jun 30, 2025
2 conditions
1 sponsor
1 location
NCT06706063
Ultrasonograpy in Hemiplegic Patients
N/A
Active, not recruiting
100 participants
Started: Apr 15, 2022 · Completed: Jun 15, 2025
3 conditions
1 sponsor
1 location
NCT05324943
A Gene Therapy Study in Patients With Gaucher Disease Type 1
PHASE1
Active, not recruiting
18 participants
Started: Apr 15, 2022 · Completed: Jul 31, 2025
1 condition
1 sponsor
10 locations
NCT05339022
Supportive Care Intervention (ROAR-LCT) for Patients With Stage IIIA, IIIB, and IV Lung Cancer, ROAR-LCT Trial
NA
Active, not recruiting
100 participants
Started: Apr 14, 2022 · Completed: Oct 1, 2025
10 conditions
2 sponsors
1 location
NCT05288166
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
PHASE3
Active, not recruiting
925 participants
Started: Apr 14, 2022 · Completed: Oct 31, 2027
17 conditions
1 sponsor
266 locations
NCT05208047
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
PHASE3
Active, not recruiting
442 participants
Started: Apr 14, 2022 · Completed: Sep 30, 2026
2 conditions
1 sponsor
126 locations
NCT04978428
Epidiolex in Obsessive Compulsive Disorder and Related Disorders
PHASE2
Active, not recruiting
4 participants
Started: Apr 14, 2022 · Completed: Nov 30, 2025
4 conditions
1 sponsor
1 location
NCT05386407
Telemedically Assisted Sampling of COVID-19 Patients - Is the Sampling Quality Sufficient
NA
Active, not recruiting
170 participants
Started: Apr 14, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT04893681
Water From Bottles to Establish Strong Teeth
NA
Active, not recruiting
200 participants
Started: Apr 14, 2022 · Completed: Jun 30, 2029
1 condition
3 sponsors
1 location
NCT05329428
PREDIN: Pregnancy and Vitamin D Intervention Study
NA
Active, not recruiting
102 participants
Started: Apr 14, 2022 · Completed: Dec 31, 2024
3 conditions
2 sponsors
1 location
NCT05330455
Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection
PHASE1/PHASE2
Active, not recruiting
74 participants
Started: Apr 14, 2022 · Completed: Apr 3, 2026
1 condition
1 sponsor
16 locations
NCT05257473
Defining Endpoints in Becker Muscular Dystrophy
N/A
Active, not recruiting
80 participants
Started: Apr 13, 2022 · Completed: May 31, 2026
4 conditions
2 sponsors
11 locations
NCT05380544
Extracorporeal Shockwave Therapy for Diabetic Foot Ulcers
NA
Active, not recruiting
77 participants
Started: Apr 13, 2022 · Completed: May 1, 2032
1 condition
1 sponsor
1 location
NCT05393180
CONVERGE Post-Approval Study (PAS)
NA
Active, not recruiting
53 participants
Started: Apr 13, 2022 · Completed: Jan 1, 2029
1 condition
1 sponsor
12 locations
NCT05165433
Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY)
PHASE1
Active, not recruiting
198 participants
Started: Apr 13, 2022 · Completed: Aug 29, 2025
2 conditions
2 sponsors
7 locations
NCT06035458
Potential Osteocatabolic Effect Caused by Anti-CGRP mAbs in Migraine Patients Treated With Anti-CGRP mAbs - an Observational Pilot Project With Prospectively Collected Health Related Data
N/A
Active, not recruiting
42 participants
Started: Apr 13, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05042128
The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma
PHASE2
Active, not recruiting
158 participants
Started: Apr 13, 2022 · Completed: Oct 1, 2025
2 conditions
2 sponsors
24 locations
NCT05274529
Effects of Personal Technology Driven Workplace Wellbeing Intervention Programme on Wellbeing, Productivity (Presenteeism) and Absenteeism - an Intervention Study
NA
Active, not recruiting
571 participants
Started: Apr 12, 2022 · Completed: Oct 31, 2026
2 conditions
4 sponsors
1 location
NCT05417269
IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS Study
PHASE1/PHASE2
Active, not recruiting
150 participants
Started: Apr 12, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05359861
Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma
PHASE2
Active, not recruiting
134 participants
Started: Apr 12, 2022 · Completed: Sep 30, 2025
1 condition
1 sponsor
34 locations
NCT06178107
Efficacy of Cholesterol-lowering L. Plantarum on Cardiometabolic Health Biomarkers in Coeliac Disease Patients
NA
Active, not recruiting
50 participants
Started: Apr 12, 2022 · Completed: Dec 21, 2025
1 condition
1 sponsor
2 locations
NCT05249426
A Study to Test Whether Different Combinations of BI 765063, Ezabenlimab, Chemotherapy, Cetuximab, and BI 836880 Help People With Head and Neck Cancer or Liver Cancer
PHASE1
Active, not recruiting
48 participants
Started: Apr 12, 2022 · Completed: Jul 31, 2026
1 condition
1 sponsor
25 locations
NCT06556628
Tympanic Thermometer Study
N/A
Active, not recruiting
1,000 participants
Started: Apr 11, 2022 · Completed: May 31, 2025
2 conditions
1 sponsor
1 location
NCT05278546
A Study of ILB2109 in Patients With Advanced Solid Malignancies
PHASE1
Active, not recruiting
48 participants
Started: Apr 11, 2022 · Completed: Feb 28, 2025
1 condition
3 sponsors
2 locations
NCT05697068
Intervention to Prevent Household and Community Spread of COVID-19 Among Latinos
NA
Active, not recruiting
256 participants
Started: Apr 11, 2022 · Completed: Oct 31, 2025
1 condition
2 sponsors
1 location
NCT05226689
Porous Baseplate in Total Knee Replacement
NA
Active, not recruiting
31 participants
Started: Apr 11, 2022 · Completed: Feb 28, 2026
1 condition
1 sponsor
2 locations
NCT05135377
Canadian Anaphylaxis Network- Predicting Recurrence After Emergency Presentation for Allergic REaction
N/A
Active, not recruiting
1,682 participants
Started: Apr 11, 2022 · Completed: Dec 31, 2025
1 condition
8 sponsors
7 locations
NCT05379088
Activity Level Monitoring Study
NA
Active, not recruiting
38 participants
Started: Apr 11, 2022 · Completed: Apr 29, 2025
2 conditions
1 sponsor
1 location
NCT05297903
XmAb20717 in Advanced Biliary Tract Cancers
PHASE2
Active, not recruiting
27 participants
Started: Apr 11, 2022 · Completed: Dec 2, 2026
1 condition
2 sponsors
1 location
NCT05259436
Collaborative Approach to Examining Adversity and Building Resilience Study
NA
Active, not recruiting
300 participants
Started: Apr 11, 2022 · Completed: Jun 30, 2025
2 conditions
6 sponsors
4 locations
NCT05433051
A Comparison of Two Protocol for Maxillary Molar Intrusion Buccal Miniscrew and TPA Versus Vertical Holding Appliance
NA
Active, not recruiting
24 participants
Started: Apr 10, 2022 · Completed: Oct 30, 2024
4 conditions
1 sponsor
1 location
NCT06615362
Autogenous Dentin Derived Barrier Membrane Versus Collagen Membrane
NA
Active, not recruiting
20 participants
Started: Apr 10, 2022 · Completed: Oct 10, 2024
2 conditions
1 sponsor
2 locations
NCT05139043
Low Dose Versus Standard Dose Dexamethasone for Reduction of Swelling in Patients with Primary or Metastatic Brain Tumors
PHASE2
Active, not recruiting
26 participants
Started: Apr 9, 2022 · Completed: Sep 3, 2025
3 conditions
2 sponsors
1 location
NCT05311462
An Observational Cohort Study to Obese Patients With Weight Cycling
N/A
Active, not recruiting
180 participants
Started: Apr 8, 2022 · Completed: Dec 20, 2028
2 conditions
1 sponsor
1 location
NCT04705220
Effect of Nutritional Supplementation With Turmeric on the Cognitive Performance of Subjects With Metabolic Syndrome
NA
Active, not recruiting
100 participants
Started: Apr 8, 2022 · Completed: Oct 16, 2025
1 condition
3 sponsors
1 location
NCT05318612
Effectiveness of MR-guided LITT Therapy in Irresectable Glioblastoma (EMITT)
PHASE3
Active, not recruiting
238 participants
Started: Apr 8, 2022 · Completed: Oct 31, 2027
1 condition
4 sponsors
7 locations
NCT05228275
Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer
N/A
Active, not recruiting
549 participants
Started: Apr 8, 2022 · Completed: Sep 30, 2027
3 conditions
2 sponsors
72 locations
Previous
1
More pages
185
186
187
188
189
190
191
More pages
431
Next